Keynote and Featured Speakers
Susan C. Winckler is the Chief Risk Management Officer, as well as a lead contributor in the firm’s alliance management and regulatory consulting activities, for Leavitt Partners (LP), a health care intelligence firm. Founded by former HHS Secretary and EPA Administrator Michael O. Leavitt, the partnership advises senior executive teams about health care developments such as health insurance exchanges, Medicaid expansion, the conversion of fee-for-service payment to fee-for-value, and helps clients navigate federal regulators such as the Food and Drug Administration and the Centers for Medicare and Medicaid Services. From October 2014 to October 2015, she served as LP’s lead staff member and the interim executive director for the Health Care Transformation Task Force, an alliance of patients, payers, providers and purchasers committed to moving 75% of their businesses to value-based payment by 2020. A pharmacist and attorney by training,
From late 2009 to mid-2014, Winckler simultaneously served as a Senior Advisor with LP and as the President and Chief Executive Officer of the Food and Drug Law Institute (FDLI), a nonprofit 501(c)(3) organization committed to providing a marketplace for discussing global food and drug law issues through conferences, publications and member interaction. From January 2007 to June 2009, she served as the Chief of the Staff for the Food and Drug Administration within HHS. In that capacity, she proved integrated policy analysis and strategic consultation to the Commissioner and senior officials on significant agency issues and programs. Winckler also led the operations of the Office of Legislation, Office of External Relations, Office of Public Affairs, and Office of the Executive Secretariat.
Prior to joining FDA, Winckler was the Vice President for Policy and Communications and Staff Counsel for the American Pharmacists Association (APhA). Winckler served as the primary spokesperson for APhA during media interviews, and was APhA’s senior lobbyist. Previous positions with the Association include Group Director, Policy and Advocacy; Director, Policy and Legislation; Director, Practice Affairs, and Manager, Special Projects. Prior to joining APhA, Winckler directed the implementation of the Iowa Medicaid Drug Prior Authorization Program for the Unisys Company, and worked for the Iowa Pharmacists Association (now the Iowa Pharmacy Association) and a community pharmacy in Iowa.
She has been recognized as a Fellow of the American Pharmacists Association, a Distinguished Alumna of the University of Iowa College of Pharmacy, a Distinguished Young Alumna by the University of Iowa Foundation, a Woman of Distinction by Alpha Xi Delta Fraternity, and elected as a Distinguished Fellow in Public Policy to the National Academies of Practice, Pharmacy Academy. She delivered the William A. Zellmer Lecture for the American Society of Health-System Pharmacists and was elected a Trustee of the United States Pharmacopeial Convention (USP) for the 2015-2020 term. Winckler is a graduate of the University of Iowa College of Pharmacy and the Georgetown University Law Center, magna cum laude. She is licensed to practice pharmacy in Iowa and admitted to the bar in the Commonwealth of Virginia.
Lucinda Maine serves as Executive Vice President and CEO of the American Association of Colleges of Pharmacy. As the leading advocate for high quality pharmacy education, AACP works to develop strong academic scholars and leaders, to support excellent professional doctoral and postgraduate degree programs and build relations with key constituency groups both inside and external to the profession of pharmacy.
Prior to assuming her current role in July 2002, Maine served as Senior Vice President for policy, planning and communications with the American Pharmacists Association (APhA). Analyzing trends in healthcare, assessing the implications for pharmacy practice and advocating appropriate recognition for all pharmacists were her top priorities at APhA.
Maine is a pharmacy graduate of Auburn University and received her doctorate at the University of Minnesota. She served on the faculty at the University of Minnesota where she practiced in the field of geriatrics and was an associate dean at the Samford University School of Pharmacy. Her past research includes projects on aging, pharmacy manpower and pharmacy-based immunizations.
Maine has been active in leadership roles in and out of the profession. Prior to joining the APhA staff she served as speaker of the APhA House of Delegates and as an APhA trustee. She currently serves as Treasurer and a member of the Executive Committee for Research!America and is an Executive Committee member of the American Foundation for Pharmaceutical Education.
Jenelle Sobotka is Professor and Endowed Chair of Pharmacy Practice at Ohio Northern University Raabe College of Pharmacy. She is responsible for enhancing the professional leadership and innovative patient care components in the students’ curriculum. She also teaches in the area of global and national health policy, and the role of the pharmacist in self-care.
Sobotka received her BSPh and PharmD degrees from the University of Iowa. Her early career roles included community pharmacy, clinical specialist/internal medicine (VA Medical Center), association management, industry, and academia. She was Associate Director of the Iowa Pharmacy Association and Director of the Iowa Center for Pharmaceutical Care (ICPC) – a coordinated effort between the Iowa colleges and professional society to change pharmacy practice that gained both national and international recognition. ICPC received the 1999 APhA Foundation’s Pinnacle Award for their work to advance patient care practice. Sobotka co-authored the book, A Practical Guide to Pharmaceutical Care. Prior to joining ONU, Sobotka was Director of Professional Relations for Procter & Gamble.
Sobotka was the 2012-13 APhA President and has served two terms with the APhA Board of Trustees. She was recently elected to the Executive Committee of the Academic Section of the Federation of International Pharmacists, FIP. Sobotka has also dedicated time, energy, and leadership to public initiatives, through service on the Hardin County Memorial Hospital – Quality Committee, and former service to the American Academy of Pediatricians – Ohio Chapter, Foundation Board Member, and the St. Vincent de Paul Charitable Pharmacy, Cincinnati, Board member.
Sobotka has received several honors and awards including the 2008 Kappa Epsilon National Career Achievement award, the 2003 University of Iowa Rho Chi Honorary Alumni Award, and was recognized as an APhA Fellow in 2003. She was presented an Honorary Degree by Western University and honored as a Fellow of the Hong Kong Academy of Pharmacy. She is also a Distinguished Fellow and Member of the National Academies of Practice.
Maureen Donovan is the Associate Dean for Undergraduate Programs and Professor of Pharmacy at the University of Iowa College of Pharmacy. Donovan leads a research group involved in the investigation of drug absorption mechanisms. Her research focuses primarily on respiratory drug delivery, with an emphasis on nasal drug absorption and disposition. She has directed over 40 Master of Science and PhD students and visiting scholars.
Donovan received her Bachelor of Science in Pharmacy from the University of Minnesota in 1983 and a PhD in Pharmaceutics from the University of Michigan in 1989. In 2005, she was named the UI College of Pharmacy Teacher of the Year. She has been a review panel member for both the NIH and NSF and chaired the NIH Emerging Technologies in Neuropharmacology/Neuroscience SBIR study section from 2009-2011. Donovan is a member of the American Association of Colleges of Pharmacy and served as the 1998-99 chair of the Section of Teachers of Pharmaceutics, and she completed an AACP Academic Leadership Fellowship during 2005.
She is a member of the American Association of Pharmaceutical Scientists and was elected to the AAPS Executive Council and served as Treasurer from 1998-2000. Dr. Donovan also served on the Board of Directors of the Society for Women’s Health from 2007-2009, and the Board of Trustees of the Eastern Iowa Chapter of the Crohn’s and Colitis Foundation of America from 1992-1995.
Panel on Mentorship
Melissa Murer Corrigan, PharmD, moderator
Melissa Murer Corrigan, BSPh, RPh, serves as ACT’s Vice President, Social Impact Strategy and Programs. Prior to joining ACT, she served as the founding CEO of the Pharmacy Technician Certification Board in Washington, D.C. ACT is an independent, not-for-profit organization helping people achieve education and workplace success. She leads ACT’s efforts on Corporate Giving and served as Chair for ACT’s United Way Campaign. Murer Corrigan also is an Adjunct Assistant Professor in the Department of Pharmacy Practice at the UI College of Pharmacy and serves on the UI College of Pharmacy Executive Leadership Board. Murer Corrigan currently serves on the Board of Directors for Corridor Women Connect.
As a national leader in pharmacy, and founding Executive Director and CEO for the Pharmacy Technician Certification Board (PTCB), she created an organization that provided credentials to over 500,000 pharmacy technicians nationwide during her leadership tenure (1995-2011). While at PTCB, she created strategic alliances with major pharmacy employers such as Walgreens, CVS and Target. Her work has contributed valuable career tools to veterans, working learners, pharmacist students and others from underserved backgrounds seeking advancement.
She is a graduate of Drake University College of Pharmacy and Health Sciences. Murer Corrigan received the 2010 Drake University College of Pharmacy’s highest honor, the Weaver Medal of Honor. She is a recognized expert on credentialing, health certification, pharmacy workforce and leadership. Murer Corrigan, a past president of the Institute for Credentialing Excellence received the association’s distinguished Certification Industry Leadership Award in 2008. She also was President of the Board of Directors for the Council on Credentialing in Pharmacy. In 2012, Murer Corrigan received the Henry Cade Memorial Award from the National Association of Boards of Pharmacy. In 2015, she was named a Fellow of the American Society of Health-System Pharmacists. In 2016, she was named a Fellow of the American Pharmacists Association.
Leslie Williams, BSN, MBA, panelist
Leslie Williams is Director, Founder, President, and CEO of ImmusanT. The company is developing a revolutionary therapeutic vaccine and companion diagnostic technology for treatment of Celiac disease and is expanding the technology to other immune mediated diseases, beginning with T1D.
Williams has extensive industry experience in pharmaceuticals, device/equipment and venture capital. As Ventaira President/CEO she transformed the company into a significant player in the pulmonary-drug-delivery market and managed its acquisition. While President and CEO of Ventaira Pharmaceuticals, she was recognized as one of the top 100 leaders in life sciences by PharmaVOICE magazine.
Prior to Ventaira, Williams was Director of Marketing for INO Therapeutics, Inc., where she played a significant role in the NDA submission for INOmax (nitric oxide) for inhalation, a drug for treating pulmonary hypertension. Among her many accomplishments, she helped orchestrate the New Drug Application submission to the FDA for INOmax for inhalation. Responsible for the commercial aspects of INOmax’s U.S. market introduction, from setting objectives and strategy to developing key constituency groups and expert advisory boards, as well as representing INO Therapeutics on Capitol Hill,
Williams also assisted with expansion of the INO-therapy platform into the European marketplace. (The company was acquired by Ikaria Holdings in 2007 for some $670 million.) Her prior pharmaceutical industry experience includes commercial positions at Merck and GlaxoSmithKline, and drug-delivery and -monitoring experience at Datex-Ohmeda (formerly Ohmeda, Inc.). She was a venture partner at Battelle Ventures where she sourced and evaluated deals and assisted early-stage technology companies with strategy, management, business development and M&A. She currently serves on the Boards of Hepregen Corporation, CDI Bioscience and The Capital Network (TCN) and is on the Editorial Advisory Board of Life Science Leader. She serves as a mentor in the Boston University Kindle Program as well as Propel Careers.
Williams holds an MBA from Washington University, John Olin School of Business, and a BS degree with honors in nursing from the University of Iowa. Before entering industry, she was a critical-care nurse at Duke University, Medical College of Virginia and at the University of Iowa.
Kelly Brock, PharmD, panelist
Kelly Brock is the President of KB Pharmacy Solutions, Inc., a healthcare consulting company focused on advancing the profession of pharmacy that she founded in 2010. Her passion for teaching and helping pharmacists expand patient care services is the driving force behind her company’s mission. Prior to forming her company, Brock worked in an academic position that allowed her to teach at a college of pharmacy and practice in a primary care clinic. There, she had the opportunity to work in collaboration with primary care physicians to help patients manage their chronic diseases and to teach student pharmacists about this model of care. Her career path has provided her with opportunities to work in community pharmacies, primary care clinics, an urgent care center, and a specialty clinic.
Along with her pharmacy practice experience, Brock has always had an interest in research and teaching. She has authored professional journal publications related to her work on collaborative working relationships between pharmacists and physicians and documentation of patient care services in community pharmacies. Throughout her career, Brock has been actively involved in teaching pharmacists and student pharmacists how to expand their practices in areas such as immunizations, over-the-counter consultations, and chronic disease state management.
Currently, Brock is serving as a community coordinator for Project IMPACT: Diabetes, a national initiative that aims to improve care for patients with diabetes. As a community coordinator, she has been actively involved in helping communities develop or expand their models of care to include pharmacists as part of the community-based interdisciplinary team caring for patients with diabetes.
She is an active member of the American Pharmacists Association and the California Pharmacists Association and is the Chair of the UI College of Pharmacy Genesis Board.
Brock received her PharmD from the University of Iowa College of Pharmacy in 2002. She then completed a pharmacy practice residency with an emphasis in community care at The Ohio State University.
Brittany Bruch, PharmD, panelist
Brittany Bruch graduated from the University of Iowa College of Pharmacy in May 2014. She completed her PGY1 residency with a focus in ambulatory care at the University of Iowa Hospitals and Clinics and is currently completing her PGY2 in ambulatory care. Following residency, she will begin her career as a Clinical Pharmacy Specialist within the Pulmonary Division of the Pediatric Specialty Clinic at the University of Iowa Hospitals and Clinics.
Brittany’s main interest areas include teaching, pediatrics, and chronic disease management. She looks forward to starting her career with the University of Iowa and being closely involved with the advancement of ambulatory care pharmacy services.
Victoria Parker, PhD candidate, panelist
Victoria Parker is a third-year PhD candidate in the UI College of Pharmacy's Medicinal and Natural Products Chemistry program. Her current research focuses on the inhibition of steroid hormone sulfation upon exposure to commonly occurring airborne polychlorinated biphenyls and its potential for altering human adipocyte differentiation. She received her B.S in Chemistry/ Pre-Medicine from Norfolk State University where she was also a recipient of the DNIMAS Full Ride scholarship. She is a 2016 ASPET Washington Fellow, 2016 Summer intern for SC Johnson in RD&E. and 2015 National GEM Consortium Fellow.
She aspires to become a medical scientist and plans to conduct translational research in the field of oncology upon receiving her PhD and MD. In addition to conducting research, she has a strong passion for increasing the number of the number of underrepresented students in science, technology, engineering, and mathematics (STEM) through mentoring.In her spare time, she serves as a mentor for the Iowa Biosciences Academy, President of the University of Iowa Chapter of NOBCChE, Senator for the College of Pharmacy in the Graduate Student Senate, and an active member of Delta Sigma Theta Sorority, Inc.